Telehealth weight loss · Delaware
Compounded Tirzepatide in Delaware: Online Access As Low As $125/Month
Delaware is home to 1.0 million residents, with 35.2% of adults meeting clinical criteria for obesity. Delaware has a disproportionately high rate of obesity-related hospitalizations per capita, with cardiovascular disease and type 2 diabetes — both strongly linked to excess weight — among the leading causes of preventable death in the state.
Ozari ships compounded tirzepatide directly to Delaware residents. No in-person visits. Licensed providers. Licensed U.S. compounding pharmacy.
See If I Qualify
How it works
Three simple steps to start in Delaware.
Take the free quiz
Answer a few health questions from home in under 5 minutes.
Get your prescription
A licensed physician reviews your profile and determines the best plan for you.
Medication delivered
Your prescription ships directly to your door with free expedited delivery.
GLP-1 Therapy in Delaware: What Patients Should Know
Delaware requires health insurers to cover telehealth services on par with in-person care, and the state has adopted Medicaid telehealth expansion policies that extend to weight management consultations. The Delaware Medical Practice Act permits physicians to establish patient relationships via synchronous video, making it fully legal for Ozari-affiliated physicians to prescribe compounded medications to Delaware residents without a prior in-person visit.
Transparent pricing
Flat-rate pricing for Delaware patients. No insurance required.
Just $125/month
Save $330
Cities we serve in Delaware
Select your city for local delivery details, pricing, and tailored information.
Delaware questions
Common questions from Delaware patients about compounded tirzepatide.
Ready to start in Delaware?
Complete your intake in 10 minutes. Free shipping to Delaware.
See If I Qualify